Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Polyrizon Ltd PLRZ

Healthcare Biotechnology
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a... see more

Current News (NDAQ:PLRZ)

From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection

GlobeNewswire 1 day ago

Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product

GlobeNewswire 2 days ago

Polyrizon Announces Successful Completion of Key Manufacturing Upscaling Milestone for Its Nasal Spray Platform

GlobeNewswire 3 days ago

Polyrizon Demonstrates Reversible Broad-Spectrum Viral Blocking by Its Intranasal Barrier-Forming Formulation

GlobeNewswire November 6, 2025

Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy

GlobeNewswire October 6, 2025

Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker

GlobeNewswire September 19, 2025

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

GlobeNewswire September 12, 2025

Polyrizon Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire August 14, 2025

Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

GlobeNewswire July 22, 2025
View More News ››

Opinion & Analysis (NDAQ:PLRZ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PLRZ)

PLRZ....Cya....done for the day

No position
Iseneschal - July 23, 2025

RE:PLRZ....now it needs to bust thru $1.88

Revisde target.....should be $1.96
Iseneschal - July 23, 2025

PLRZ....now it needs to bust thru $1.88

with vols increasing and we just might have a runner ; )
Iseneschal - July 23, 2025

PLRZ.....nice lil bounce so far

Cheers to me ; )
Iseneschal - July 23, 2025

PLRZ.....I bot the dip

small position at $1.62 will add on weakness
Iseneschal - July 23, 2025

PLRZ....no bounce no glory

Now at the support I previously mentiond What's it going to be now.....let me get my head wrapped around this now ; ) Cheers !
Iseneschal - July 23, 2025
View more Bullboard ››

Southern Silver Exploration Corp.

Southern Silver Exploration Corp.

Southern Silver Exploration Corp., an exploration stage company, acquires, explores, and develops natural resource properties ...
View More »